Making science work for development

Ross Fund

Ross Fund

The Ross Fund is a £1 billion programme which will run between 2016-2021, which will develop, test and produce new products to help combat serious diseases in developing countries. 

In total over this period, approximately £400 million will be used for research, managed by the Department of Health (DH) with the support of the Department for International Development (DFID). 

DAC list of ODA recipient countriesThe key focus areas of the fund are:

Anti-microbial resistance:
Developing drugs, diagnostics and insecticides to tackle the growing threat of diseases of emerging resistance including malaria and TB . This funding will include:

  • Investing £265m in the Fleming Fund to strengthen surveillance of drug resistance and laboratory capacity in developing countries
  • Delivering the new Global AMR Innovation Fund, launched with China for research and innovation to tackle AMR
  • £115 million to develop new drugs, diagnostics and insecticides for diseases of emerging resistance (including malaria and TB)

Infectious diseases with epidemic potential
F
ocusing on the development vaccines and diagnostics to prevent and respond to future disease outbreaks, such as Ebola, that can rapidly spread if not stopped early. This includes £120 million for the UK Vaccine Network abnd funding for research to accelerate the trialling and regulation of medical technologies when an international outbreak is declared.

Neglected tropical diseases (NTDs)
Focusing on diseases that affect over a billion people worldwide, causing disability, disfigurement and death. Funding will include support for the development of products, including drugs and diagnostics, to tackle NTDs including research into how these can most effectively be delivered. The £200 million wil be used to develop prodicts, including drugs and diagnostics. It will continue the UK's considerable investments in prevention and treatment.

The government will work closely with the World Health Organisation, foundations, pharmaceutical companies, philanthropic organisations, product developers and academic institutions in delivering this fund.

Where it funds

Research funded under the Ross Fund is part of the UK’s Official Development Assistance (ODA) must have the primary purpose of promoting the economic development and welfare of Low or Middle Income Countries (LMICs) on the DAC list of ODA recipients as its main objective. 

 

Eligibility

Further details about the fund, including eligibility and information about funding calls, will be added as this information is made available.